Lunai Bioworks Inc. 8-K Filing
Ticker: LNAI · Form: 8-K · Filed: Nov 3, 2025 · CIK: 1527728
| Field | Detail |
|---|---|
| Company | Lunai Bioworks Inc. (LNAI) |
| Form Type | 8-K |
| Filed Date | Nov 3, 2025 |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Lunai Bioworks Inc. (ticker: LNAI) to the SEC on Nov 3, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.0001 (h registered Common Shares, par value $0.0001 per share LNAI The Nasdaq Stock Marke).
How long is this filing?
Lunai Bioworks Inc.'s 8-K filing is 3 pages with approximately 855 words. Estimated reading time is 3 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 855 words · 3 min read · ~3 pages · Grade level 14.1 · Accepted 2025-11-03 16:31:33
Key Financial Figures
- $0.0001 — h registered Common Shares, par value $0.0001 per share LNAI The Nasdaq Stock Marke
Filing Documents
- e6995_8-k.htm (8-K) — 51KB
- 0001731122-25-001465.txt ( ) — 214KB
- lnai-20251031.xsd (EX-101.SCH) — 3KB
- lnai-20251031_lab.xml (EX-101.LAB) — 33KB
- lnai-20251031_pre.xml (EX-101.PRE) — 22KB
- e6995_8-k_htm.xml (XML) — 4KB
Signatures
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. David Weinstein By: /s/ David Weinstein David Weinstein Chief Executive Officer Date: November 3, 2025 4